药学学报, 2018, 53(9): 1398-1405
引用本文:
张莹, 韦佳慧, 张成玲, 李攀红, 孙文威, 徐晓玉, 陈怡. 基于网络药理学的加味佛手散抑制子宫内膜侵袭转移机制研究[J]. 药学学报, 2018, 53(9): 1398-1405.
ZHANG Ying, WEI Jia-hui, ZHANG Cheng-ling, LI Pan-hong, SUN Wen-wei, XU Xiao-yu, CHEN Yi. Mechanism of Jiawei Foshou San on invasion and metastasis in endometriosis based on network pharmacology[J]. Acta Pharmaceutica Sinica, 2018, 53(9): 1398-1405.

基于网络药理学的加味佛手散抑制子宫内膜侵袭转移机制研究
张莹, 韦佳慧, 张成玲, 李攀红, 孙文威, 徐晓玉, 陈怡
西南大学药学院&中医药学院, 重庆市高校中药新药筛选重点实验室, 国家中医药管理局中药药理重点建设学科, 重庆 400715
摘要:
加味佛手散是由川芎嗪、阿魏酸加延胡索乙素组成的新中药复方。前期研究发现,加味佛手散能够抑制异位子宫内膜生长,但对异位内膜侵袭转移的作用尚不明确。本研究运用网络药理学方法分析加味佛手散作用靶点,并通过体内模型验证其对异位内膜侵袭转移的作用机制。首先,通过检索TCMID、TCMSP和SEA数据库获得加味佛手散成分靶点,检索OMIM、DisGeNET和GEO数据库获得子宫内膜异位症的靶点,采用Cytoscape 3.5.0软件构建加味佛手散成分-成分靶点和加味佛手散成分-子宫内膜异位症靶点网络,并将关键靶点的信息上传至DAVID数据库进行通路富集分析,发现加味佛手散可能通过调控MMP2、MMP9、TIMP1、ICAM1和VEGFA等66个关键靶点,干预雌激素、HIF-1、TNF和GnRH信号通路等115条通路发挥作用,其中MMP-TIMP为一类关键靶点。其次,加味佛手散体内能显著抑制异位内膜组织的生长,下调MMP-2和MMP-9,上调TIMP-1表达,进而抑制异位内膜侵袭转移。此结果为加味佛手散的研究提供了药效学依据。
关键词:    加味佛手散      子宫内膜异位症      网络药理学      侵袭转移      作用机制     
Mechanism of Jiawei Foshou San on invasion and metastasis in endometriosis based on network pharmacology
ZHANG Ying, WEI Jia-hui, ZHANG Cheng-ling, LI Pan-hong, SUN Wen-wei, XU Xiao-yu, CHEN Yi
College of Pharmaceutical Sciences and Chinese Medicine, Chongqing Key Laboratory of New Drug Screening from Traditional Chinese Medicine, Pharmacology of Chinese Materia Medica-the Key Discipline Constructed by the State Administration of Traditional Chinese Medicine, Southwest University, Chongqing 400715, China
Abstract:
Jiawei Foshou San is a new Chinese medicine compound consisting of ligustrazine, ferulic acid and fumarate. Previously Jiawei Foshou San inhibited the growth of endometriosis with unclear mechanism, especially in metastasis and invasion. In this study, network pharmacology analysis was performed to explore potential mechanism of Jiawei Foshou San on endometriosis. Jiawei Foshou San compound targets were purchase from TCMID, TCMSP and SEA database. Endometriosis targets were collected from OMIM, DisGeNET and GEO database. Networks of Jiawei Foshou San compound-compound targets and compound target-endometriosis target were established with Cytoscape 3.5.0 software. Key targets were analyzed for pathway enrichment through DAVID database. It was found that Jiawei Foshou San regulated 66 core targets (MMP2, MMP9, TIMP1, ICAM1, VEGFA, et al.) and affected 115 pathways, such as estrogen, HIF-1, TNF and GnRH signaling pathways. MMP-TIMP were uncovered as one cluster of the core targets. Furthermore, Jiawei Foshou San significantly suppressed the growth of ectopic endometrium. Meanwhile, invasion and metastasis were restrained after treating with Jiawei Foshou San through decreasing MMP-2 and MMP-9, increasing TIMP-1. In brief, these results provide a pharmacodynamic basis for the study of Jiawei Foshou San.
Key words:    Jiawei Foshou San    endometriosis    network pharmacology    invasion and metastasis    mechanism   
收稿日期: 2018-07-24
DOI: 10.16438/j.0513-4870.2018-0674
基金项目: 国家自然科学基金资助项目(81773984,81402441);重庆市卫生局中医药科研项目(zy201602125);西南大学“国家级大学生创新创业训练计划”项目(201710635073).
通讯作者: 陈怡,Tel:86-23-68251225,E-mail:rachelcy@swu.edu.cn
Email: rachelcy@swu.edu.cn
相关功能
PDF(491KB) Free
打印本文
0
作者相关文章
张莹  在本刊中的所有文章
韦佳慧  在本刊中的所有文章
张成玲  在本刊中的所有文章
李攀红  在本刊中的所有文章
孙文威  在本刊中的所有文章
徐晓玉  在本刊中的所有文章
陈怡  在本刊中的所有文章

参考文献:
[1] Ma X, Hui Y, Lin L, et al. Possible relevance of tumor-related genes mutation to malignant transformation of endometriosis[J]. Eur J Gynaecol Oncol, 2016, 37:89-94.
[2] Mihailovici A, Rottenstreich M, Kovel S, et al. Endometriosisassociated malignant transformation in abdominal surgical scar:a PRISMA-compliant systematic review[J]. Medicine, 2017, 96:e9136.
[3] Borrelli GM, Abrao MS, Taube ET, et al. Immunohistochemical investigation of metastasis-related chemokines in deepinfiltrating endometriosis and compromised pelvic sentinel lymph nodes[J]. Reprod Sci, 2015, 22:1632-1642.
[4] Chui MH, Wang TL, Shih IM. Endometriosis:benign, malignant, or something in between?[J]. Oncotarget, 2017, 8:78263-78264.
[5] Shan J, Cheng W, Zhai DX, et al. Meta-analysis of Chinese traditional medicine Bushen Huoxue prescription for endometriosis treatment[J]. Evid Based Complement Alternat Med, 2017, 2017:5416423.
[6] Wen Y, Wang Y, Feng TT, et al. Differential proteomics analysis of endometriosis in blood stasis syndrome[J]. Chin J Integr Med, 2017. DOI:10.1007/s11655-017-2401-4.
[7] Zhao RH. Strategies for activating blood circulation-regulating Gan (liver)-tonifying Shen (kidney) sequential therapy of endometriosis-associated infertility[J]. Chin J Integr Med, 2018. DOI:10.1007/s11655-018-2931-9.
[8] Tang Q, Shang F, Wang X, et al. Combination use of ferulic acid, ligustrazine and tetrahydropalmatine inhibits the growth of ectopic endometrial tissue:a multi-target therapy for endometriosis rats[J]. J Ethnopharmacol, 2014, 151:1218-1225.
[9] Ning K, Zhao X, Poetsch A, et al. Computational molecular networks and network pharmacology[J]. Biomed Res Int, 2017. DOI:10.1155/2017/7573904.
[10] Wang Y, Lin W, Li C, et al. Multipronged therapeutic effects of Chinese herbal medicine Qishenyiqi in the treatment of acute myocardial infarction[J]. Front Pharmacol, 2017, 8:98-110.
[11] Ru JL. Construction and Utilization of Traditional Chinese Medicine System Pharmacology Database and Analysis Platform (中药系统药理学数据库和分析平台的构建和应用)[D]. Xianyang:North West Agriculture and Forestry University, 2015.
[12] Ru J, Li P, Wang J, et al. TCMSP:a database of systems pharmacology for drug discovery from herbal medicines[J]. J Cheminform, 2014, 6:13-19.
[13] Keiser MJ, Roth BL, Armbruster BN, et al. Relating protein pharmacology by ligand chemistry[J]. Nat Biotechnol, 2007, 25:197-206.
[14] Li X, Wu LH, Fan XH, et al. Network pharmacology study on major active compounds of Fufang Danshen formula[J]. China J Chin Mater Med (中国中药杂志), 2011, 36:2911-2915.
[15] Bravo A, Queralt-Rosinach N, Pinero J, et al. DisGeNET:a comprehensive platform integrating information on human disease-associated genes and variants[J]. Nucleic Acids Res, 2017, 45:D833-D839.
[16] Li G, Xu B, Liang XZ, et al. Study on the molecular mechanism of osteoporosis treated by epimedium based on network pharmacology[J]. Chin Pharm Bull (中国药理学通报), 2018, 34:267-273.
[17] Szklarczyk D, Morris JH, Cook H, et al. The STRING database in 2017:quality-controlled protein-protein association networks, made broadly accessible[J]. Nucleic Acids Res, 2017, 45:D362-D368.
[18] Chai X, Meng YK, Bai ZF, et al. Mechanism of anti-hepatitis B virus activity of tonkinensis based on biological targets network[J]. Acta Pham Sin (药学学报), 2018, 53:396-402.
[19] Jiao X, Sherman BT, Huang DW, et al. DAVID-WS:a stateful web service to facilitate gene/protein list analysis[J]. Bioinformatics, 2012, 28:1805-1806.
[20] Liu W, Wang LX, Guo CX. The effects of lauromacrogol injection into rat endometrial cysts:a preliminary experimental study[J]. Arch Gynecol Obstet, 2016, 294:556-559.
[21] Duan LJ, Wang JY, Sun XT, et al. The role and significance of endomorphin-1 and μ-opioid receptor in rats with endometriosis[J]. Gynecol Endocrinol, 2016, 32:912-915.
[22] Li Z, Takino T, Endo Y, et al. Activation of MMP-9 by membrane type-1 MMP/MMP-2 axis stimulates tumor metastasis[J]. Cancer Sci, 2017, 108:347-353.
[23] Jana S, Chatterjee K, Ray AK, et al. Regulation of matrix metalloproteinase-2 activity by COX-2-PGE2-pAKT axis promotes angiogenesis in endometriosis[J]. PLoS One, 2016, 11:e0163540.
[24] Huang YH, Shen L, Cai A, et al. Effect of warming Yang and removing blood stasis method on matrix metalloproteinases/tissue inhibitor metalloproteinases levels secreted by cultured endometrial cells from patients with endometriosis[J]. J Tradit Chin Med (中医杂志), 2015, 35:571-576.
[25] Yi KW, Kim SH, Ihm HJ, et al. Increased expression of p21-activated kinase 4 in adenomyosis and its regulationof matrix metalloproteinase-2 and -9 in endometrial cells[J]. Fertil Steril, 2015, 103:1089-1097.
[26] Szymanowski K, Mikolajczyk M, Wirstlein P, et al. Matrix metalloproteinase-2(MMP-2), MMP-9, tissue inhibitor of matrix metalloproteinases (TIMP-1) and transforming growth factor-β2(TGF-β2) expression in eutopic endometrium of women with peritoneal endometriosis[J]. Ann Agric Environ Med, 2016, 23:649-653.
[27] Li Z, Liu H, He Z, et al. Effects of cisplatin and letrozole on surgically induced endometriosis and comparison of the two medications in a rat model[J]. Eur J Pharm Sci, 2016, 93:132-140.
[28] Kim JH, Woo JH, Kim HM, et al. Anti-endometriotic effects of pueraria flower extract in human endometriotic cells and mice[J]. Nutrients, 2017, 9:212-226.
[29] Gao L, Wang KX, Zhou YZ, et al. Uncovering the anticancer mechanism of compound kushen injection against HCC by integrating quantitative analysis, network analysis and experimental validation[J]. Sci Rep, 2018, 8:624-639.
[30] Xue M, Zhang L, Yang L, et al. Effect of Chinese herbal medicine for activating blood circulation and detoxifying on expression of inflammatory reaction and tissue damage related factors in experimental carotid artery thrombosis rats[J]. Chin J Integr Med, 2010, 16:247-251.
[31] Sun J, Zhu Y, Zhang L, et al. Effects of xuelian injection on cerebral TNF-α, IL-1β and MMP-9 in rats experienced focal cerebral ischemia/reperfusion[J]. Int J Clin Exp Med, 2014, 7:2632-2638.
[32] Salameh A, Dhein S. Strategies for pharmacological organoprotection during extracorporeal circulation targeting ischemiareperfusion injury[J]. Front Pharmacol, 2015, 6:296-308.
[33] Zhao FL, Li GC, Yang YH, et al. A network pharmacology approach to determine active ingredients and rationality of herb combinations of modified-Simiaowan for treatment of gout[J]. J Ethnopharmacol, 2015, 168:1-16.
[34] Zhou W, Wang Y. A network-based analysis of the types of coronary artery disease from traditional Chinese medicine perspective:potential for therapeutics and drug discovery[J]. J Ethnopharmacol, 2014, 151:66-77.
[35] Fei X, Zhang X, Wang Q, et al. Xijiao Dihuang decoction alleviates ischemic brain injury in MCAO rats by regulating inflammation, neurogenesis, and angiogenesis[J]. Evid Based Complement Alternat Med, 2018. DOI:10.1155/2018/5945128.
[36] Chen ZZ, Gong X. Effect of Hua Yu Xiao Zheng decoction on the expression levels of vascular endothelial growth factor and angiopoietin-2 in rats with endometriosis[J]. Exp Ther Med, 2017, 14:5743-5750.
[37] Granese R, Perino A, Calagna G, et al. Gonadotrophinreleasing hormone analogue or dienogest plus estradiol valerate toprevent pain recurrence after laparoscopic surgery for endometriosis:a multi-center randomized trial[J]. Acta Obstet Gynecol Scand, 2015, 94:637-645.
[38] Leavy O. Reproductive immunology:evading immunosurveillance in endometriosis[J]. Nat Rev Immunol, 2015, 15:729.
[39] Simmen RC, Kelley AS. Reversal of fortune:estrogen receptor-beta in endometriosis[J]. J Mol Endocrinol, 2016, 57:F23-F27.
[40] Tosti C, Biscione A, Morgante G, et al. Hormonal therapy for endometriosis:from molecular research to bedside[J]. Eur J Obstet Gynecol Reprod Biol, 2017, 209:61-66.
[41] Voloshenyuk TG, Gardner JD. Estrogen improves TIMPMMP balance and collagen distribution in volume-overloaded hearts of ovariectomized females[J]. Am J Physiol Regul Integr Comp Physiol, 2010, 299:R683-R693.
[42] Raga F, Casan EM, Wen Y, et al. Independent regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1(TIMP-1), and TIMP-3 in human endometrial stromal cells by gonadotropin-releasing hormone:implications in early human implantation[J]. J Clin Endocrinol Metab, 1999, 84:636-642.
[43] Yang YN, Wang F, Zhou W, et al. TNF-alpha stimulates MMP-2 and MMP-9 activities in human corneal epithelial cells via the activation of FAK/ERK signaling[J]. Ophthalmic Res, 2012, 48:165-170.
相关文献:
1.翟园园, 刘其南, 徐佳, 姚卫峰, 包贝华, 曹雨诞, 张丽, 丁安伟.基于网络药理学的二至丸保肝作用机制研究[J]. 药学学报, 2018,53(4): 567-573
2.王珂欣, 高丽, 周玉枝, 张建琴, 秦雪梅, 杜冠华.基于网络药理学的苦参碱抗肝癌作用及机制研究[J]. 药学学报, 2017,52(6): 888-896
3.赵蕾, 武嫣斐, 高耀, 向欢, 秦雪梅, 田俊生.基于网络药理学的百合地黄汤干预心理亚健康作用机制研究[J]. 药学学报, 2017,52(1): 99-105
4.孙莉敏, 刘丽芳, 朱华旭, 朱宝杰, 张启春.基于网络药理学的黄连解毒汤治疗阿尔兹海默症的作用机制研究[J]. 药学学报, 2017,52(8): 1268-1275
5.陶瑾, 姜民, 陈露莹, 侯媛媛, 张德芹, 邱峰, 白钢.基于中药性味理论和网络药理学方法的治疗消渴方药作用机制研究[J]. 药学学报, 2017,52(2): 236-244
6.牟海栋, 屠鹏飞, 姜勇.基于网络药理学的肉桂温经通脉的作用机制研究[J]. 药学学报, 2016,51(11): 1724-1733
7.韩彦琪, 许浚, 张喜民, 张铁军, 任一杰, 刘昌孝.基于网络药理学的元胡止痛滴丸治疗原发性痛经的作用机制研究[J]. 药学学报, 2016,51(3): 380-387
8.尚芳红, 俸珊, 陈乾, 陈先进, 张继芬, 徐晓玉.加味佛手散胶囊对大鼠和人肝微粒体CYP450酶活性的抑制作用[J]. 药学学报, 2016,51(6): 926-930
9.白雨, 范雪梅, 孙瀚, 王义明, 梁琼麟, 罗国安.基于网络药理学的罗格列酮复方作用机制探讨[J]. 药学学报, 2015,50(3): 284-290